Search Results
Aug 24, 2026, 03:01 ET ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
rare diseases, announced that it has been finally selected for the 2026 Investment and Financing-Linked Technology Development Program (Global TIPS R&D), organized by the Ministry of SMEs and Startups (MSS) and the Korea Technology and Information Promotion Agency for SMEs (TIPA).
More news about: ImmunoForge Co., Ltd.
Aug 24, 2026, 02:25 ET NKT qualifies 525 kV HVDC subsea power cable system for operation at 90 °C
https://news.cision.com/nkt/r/nkt-qualifies-525-kv-hvdc-subsea-power-cable-system-for-operation-at-90--c,c4386800The following files are available for download:
More news about: NKT
Aug 24, 2026, 01:48 ET Skanska to build datacenter near Prague, Czechia, for CZK 2.1 billion, about SEK 930M
https://news.cision.com/skanska/r/skanska-to-build-datacenter-near-prague--czechia--for-czk-2-1-billion--about-sek-930m,c4386683The following files are available for download:
More news about: Skanska
Aug 24, 2026, 01:21 ET GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Receives Drug Approval in India and Taiwan
immunoglobulin G) in 2024. In line with its mission to meet the demands of future healthcare, GC Biopharma continues to drive innovation by leveraging its core R&D capabilities in engineering of proteins, mRNAs, and lipid nanoparticle (LNP) drug delivery platform to develop therapeutics for the field of rare disease
More news about: GC Biopharma
Aug 24, 2026, 01:03 ET Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
Genentech will take over development starting with Phase 2 clinical trials.In-Young Choi, Senior Executive Vice President, Head of R&D Division of Hanmi Pharm stated, "The paradigm of obesity treatment is evolving beyond simple weight reduction toward improving body composition and
More news about: Hanmi Pharm. Co., Ltd.
Aug 24, 2026, 00:40 ET Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
Genentech will take over development starting with Phase 2 clinical trials.In-Young Choi, Senior Executive Vice President, Head of R&D Division of Hanmi Pharm stated, "The paradigm of obesity treatment is evolving beyond simple weight reduction toward improving body composition and
More news about: Hanmi Pharm. Co., Ltd.
Aug 23, 2026, 23:05 ET Pulnovo Medical Announces First Two U.S. Patients Enrolled in PULSE-LHD IDE Clinical Trial of Pulmonary Artery Denervation in Treating Pulmonary Hypertension Associated with Left Heart Disease
[1] Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiery JL. Left ventricular heart failure and pulmonary hypertension. European heart journal. 2016 Mar 21;37(12):942-54.
More news about: Pulnovo Medical
Aug 23, 2026, 21:54 ET Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
driving long-term efforts to establish global clinical infrastructure for its lead pipelines, expand global strategic partnerships, and recruit top-tier R&D researchers in the U.S."Joining Lilly Gateway Labs in San Diego represents a meaningful milestone for Rznomics' proprietary RNA platform," said
More news about: Rznomics
Aug 23, 2026, 21:00 ET Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
costimulatory moieties, further broadening our comprehensive TCE engineering toolbox. We are also deepening the integration of AI across our R&D engine. By linking multi-omics analysis with internally generated protein datasets, our AI platform identifies novel targets and target combinations,
More news about: Antengene Corporation Limited
Aug 23, 2026, 02:00 ET New Taipei's Tech Ecosystem Leaps into the Middle East: 20 Companies to Showcase at LEAP 2026
will present a diverse portfolio of innovative technologies, smart applications, and integrated solutions, highlighting New Taipei companies' strong R&D capabilities and ability to deliver customized services. The pavilion will provide global buyers with a broad range of competitive partnership opportunities.The
More news about: New Taipei City Government
Aug 22, 2026, 12:00 ET Genye Technology Opens New LA-Area Branch and Technology Demonstration Center in Southern California
normally require a trip to the manufacturing facility can now be answered locally.The center also creates a direct feedback loop between Genye's R&D teams and the North American market. Feedback from hands-on testing and customer discussions flows directly back to product development, speeding up
More news about: Genye Technology
Aug 22, 2026, 04:01 ET Chandigarh University Hosts Global Architectural Voices to Deliberate on Technology, Heritage and Future of Architecture
https://mmx.prnewswire.com/media/MS1973975/ICTAC_event_collage_group_top_speakers_below.jpg?id=OA2903341&token=eyJhbGciOiJkaXIiLCJlbmMiOiJBMjU2R0NNIn0..vyIt1-Qpobw4ZX4W.1QxGS5VNCjhZxaRW63yXMYGuyzRl3V5MN026BJrGy-idYn6FksvyBs_KeGyGGF7bW3cGTm1K5dNvwn7BjCyidmdcdgF5-3NcXTllKXG8B_gTzNjzLaZtpoAyvN48-dr5oIs.O8b-cgZp-R0v_7scTU0tvg
More news about: Chandigarh University
Aug 21, 2026, 22:29 ET Global Times: China's economic performance will remain within a reasonable range in H2, meet annual goals
the Chinese government's efforts to boost domestic demand, safeguard and improve people's livelihoods, strengthen public services, and enhance local R&D capabilities will bring bright prospects to the Chinese economy and also create new scenarios and opportunities for multinational companies to deepen
More news about: Global Times
Aug 21, 2026, 20:40 ET Morpho lance une imprimante UV de bureau sur Kickstarter, réinventant ainsi le travail créatif grâce à une nouvelle vision
développeurs informatiques, de concepteurs de produits et d'experts en fabrication. Le fondateur, Mingyu « Brett » Wang, a déjà dirigé les équipes de R&D et d'ingénierie chez DJI et détient plus de 500 brevets internationaux. Pour Wang, Morpho est un outil intuitif et fiable qui met la création physique
More news about: Morpho
Aug 21, 2026, 13:51 ET GRAMMY AWARD-WINNING HIP-HOP ICON LIL' KIM TO PRESENT "HARD CORE SYMPHONY" AN EXCLUSIVE ONE-NIGHT-ONLY ORCHESTRAL PERFORMANCE TO CELEBRATE THE LEGACY OF HER ICONIC DOUBLE-PLATINUM DEBUT ALBUM, "HARD CORE"
Illharmonic Orchestra is an all-Black orchestral ensemble renowned for its blend of hip-hop and R&B coupled with their sophisticated live instrumentations. This unique performance will bridge hip-hop and R&B music, transforming some of Lil' Kim's most celebrated songs for a symphonic experience.Fans
More news about: Lil’ Kim
Aug 21, 2026, 13:43 ET Zhang Ziyi : le nouveau visage de la gamme Precious de Clarins
Clarins compte plus de 8 000 collaborateurs répartis entre son siège social à Paris, ses 28 filiales à travers le monde, ses deux laboratoires de R&D et ses trois sites industriels en France.Jonathan Zrihen, président-directeur général, ainsi que deux directeurs généraux, le Dr Olivier Courtin-Clarins
More news about: Clarins
Aug 21, 2026, 12:45 ET Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to Insulet Corporation (PODD) have opportunity to lead the securities fraud class
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Aug 21, 2026, 12:34 ET /C O R R E C T I O N -- Kessler Topaz Meltzer & Check, LLP/
More news about: Kessler Topaz Meltzer & Check, LLP
Aug 21, 2026, 12:24 ET Zhang Ziyi: the new face of Clarins Precious
skin care, nutri-cosmetics and beauty tech. The Clarins Group has over 8,000 employees across its Paris head office, 28 subsidiaries worldwide, two R&D Laboratories and three industrial sites in France.Jonathan Zrihen, President and CEO, and two Managing Directors, Dr Olivier Courtin-Clarins
More news about: Clarins
Aug 21, 2026, 12:15 ET Greenberg Traurig Earns Top Recognitions in The Best Lawyers in America®, Best Lawyers: Ones to Watch® in America 2027 Editions
Joshua R. Brown: Litigation – Patent,
More news about: Greenberg Traurig, LLP
Aug 21, 2026, 12:00 ET Wise Group plc (WSE) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to Wise Group plc (WSE) have opportunity to lead the securities fraud class action
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Aug 21, 2026, 11:50 ET Zhang Ziyi: the new face of Clarins Precious
skin care, nutri-cosmetics and beauty tech. The Clarins Group has over 8,000 employees across its Paris head office, 28 subsidiaries worldwide, two R&D Laboratories and three industrial sites in France.Jonathan Zrihen, President and CEO, and two Managing Directors, Dr Olivier Courtin-Clarins
More news about: Clarins
Aug 21, 2026, 11:45 ET Pentair plc (PNR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to Pentair plc (PNR) have opportunity to lead the securities fraud class action lawsuit.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Aug 21, 2026, 11:15 ET Simply Good Foods Company (SMPL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announces that investors with losses related to Simply Good Foods Company (SMPL) have opportunity to lead the securities fraud
More news about: The Law Offices of Frank R. Cruz, Los Angeles